Full name
MEDUNIV SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,4 | -0,2 | 0,2 | 204,1 |
EBITDA | 0,4 | 3849,8 | ||
Short time liabilities | 0,2 | 79,5 | ||
Income tax | 0 | 0 | 0 | |
Equity capital | 0,5 | 0,3 | 0,5 | 55,1 |
Operating profit (EBIT) | 0,4 | 1921,7 | ||
Assets | 0,8 | 0,7 | 0,9 | 32,7 |
Net profit (loss) | 0,3 | -0,2 | 0,2 | 204,1 |
Cash | 0,3 | 56,7 | ||
Net income from sale | 2,3 | 935,8 | ||
Liabilities and provisions for liabilities | 0,3 | 0,4 | 0,4 | 12 |
Working assets | 0,7 | 0,6 | 0,9 | 36,9 |
Depreciation | 0 | 50 | ||
Basic operational activity income | 2,3 | 4,1 | 78,8 | |
% | % | % | p.p. | |
Profitability of capital | 71 | -53,3 | 35,8 | 89,1 |
Equity capital to total assets | 60,9 | 48,1 | 56,2 | 8,1 |
Gross profit margin | 16,2 | -7,7 | 4,5 | 12,2 |
EBITDA Margin | 16,8 | 21,4 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | -184 | ||
Current financial liquidity indicator | 2.3928987979888916 | 1 | ||
Net dept to EBITDA | -0.6805827021598816 | -17 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane